| abstract |
The current invention discloses amorphous dosage forms of pharmaceutical compounds and compositions, as well as the related methods. More particularly, the current invention teaches amorphous dosage forms of DPP4 inhibitors for diabetes therapeutics, as well as methods for the preparation of amorphous drug substance and converting them into oral solid dosage forms. |